Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Levine James E.
Mar 7 18:45 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kabbinavar Fairooz
Mar 7 18:40 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Smeal Tod
Mar 7 18:40 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Erlander Mark
Mar 7 18:40 ET
Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Acorn Bioventures, L.P.(4.20%),Acorn Capital Advisors GP, LLC(4.20%), etc.
Feb 6 16:03 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Dec 19, 2023 18:39 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Nov 14, 2023 16:24 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director Markin Rodney S
Jun 20, 2023 17:08 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director Armitage James O
Jun 20, 2023 17:06 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director White Lale
Jun 20, 2023 17:05 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director PACE GARY W
Jun 20, 2023 17:04 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director Mohindru Mani
Jun 20, 2023 17:03 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Director TANNENBAUM RENEE P
Jun 20, 2023 17:02 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Smeal Tod
Mar 16, 2023 17:42 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Levine James E.
Mar 16, 2023 17:42 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Officer Kelemen Vicki
Mar 16, 2023 17:41 ET
Cardiff Oncology | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Erlander Mark
Mar 16, 2023 17:41 ET
Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caxton Corporation(2.2%),Bruce S. Kovner(2.2%), etc.
Feb 14, 2023 12:47 ET
Cardiff Oncology | 3: Initial statement of beneficial ownership of securities-Officer Kabbinavar Fairooz
Feb 9, 2023 16:50 ET
Cardiff Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(0.0%)
Feb 9, 2023 09:23 ET
No Data
No Data